• Engaging consumers

 

Kathy Hudson, Johns Hopkins University

 

Respondent: Jerry Avorn, Harvard Medical School

General discussion

3:15

SESSION 6: ORGANIZING THE RESEARCH COMMUNITY FOR CHANGE—DISCUSSION PANEL

What guiding principles are important in refining the clinical effectiveness research paradigm and in fostering the necessary changes? What issues need to be addressed in integrating trials into a lifecycle approach to evidence development? What expertise and training might be needed? What are some of the political challenges?

Chair: J. Michael McGinnis, Institute of Medicine

 

Panel discussion

Panel: Alan M. Krensky (NIH), Mark B. McClellan (Brookings Institution), Garry Neil (Johnson & Johnson), John Niederhuber (NCI), Lewis Sandy (United HealthCare)

4:30

CONCLUDING SUMMARY REMARKS AND ADJOURNMENT

J. Michael McGinnis, Institute of Medicine

Workshop Planning Committee

Robert M. Califf, MD, Duke Clinical Research Institute, Duke University

Lynn Etheredge, George Washington University

Kim Gilchrist, MD, AstraZeneca LP

Bryan Luce, PhD, MBA, United Biosource Corporation

Jonathan Perlin, MD, PhD, MSHA, FACP, HCA Inc.

Richard Platt, MD, MS, Harvard Medical School and Harvard Pilgrim



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement